A judge has refused to grant a further “indulgence” to Melbourne-based construction company Maxcon in a settled dispute with a barristers chambers, finding justice was better served by putting an end to the case despite on ongoing costs dispute.
The law firm behind a long-running class action over the 2011 floods in Queensland which reached a $440 million partial settlement last month has estimated that its legal bill to date totals around $60 million.
Ardent Leisure Group has hit back at a $310 million shareholder class action, denying that there were “obvious” risks in its Thunder River Rapids Ride ahead of a 2016 tragedy at the Dreamworld theme park which claimed four lives.
Attorney-General Christian Porter has filed defamation proceedings in the Federal Court against the ABC and journalist Louise Milligan over an online article he says made false allegations against him.
Swiss drug giant Novartis has sued generic drug maker Pharmacor to halt its launch of a generic version of the company’s top-selling MS drug Gilenya.
A judge has allowed Woolworths to include details of its internal pay review processes in an opt out notice to be sent to disgruntled current and former employees who have launched a class action against the supermarket giant.
A group of late opt out notices by group members in a class action over IAG insurance, who were egged on in part by a ‘corporate warfare’ campaign by claims management service Claimo, could result in IAG pulling the plug on a $138 million settlement.
A judge has questioned fintech company Squirrel Super’s defence in ASIC’s case alleging it made false and misleading statements about returns on property investments, saying it “looked like a bit of a stretch” at first glance.
A judge has slugged the CEO of a Sydney property development company with a $32,500 penalty for underpaying a live-in nanny, but he aimed his wrath at the media for having “wrongly branded” the businessman as someone who engaged in modern slavery.
A judge overseeing a class action against Bayer-owned Monsanto over its allegedly carcinogenic weedkiller, Roundup, has declined to rule on the admissibility of expert evidence in a hearing ahead of trial next year, despite concerns about the independence of the expert witnesses for the class.